OMEGA, Local Ablative Therapy in Oligometastatic NSCLC

NCT03827577 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

195

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

PROCEDURE: Surgical removal of primary and/or of all oligometastases
RADIATION: Non-surgical LAT
DRUG: Standard medical therapy

Sponsor

Azienda Ospedaliera Universitaria Integrata Verona

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]